 AccentedTouch |
Norvatis' Xolair Aids In The Treatment of Asthma Among Children
AccentedTouch “A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in … |
View full post on asthma – Google News